Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results| (NASDAQ: CRVS) | Delayed: 12.56 +0.65 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.91 | 52 Week High | $17.77 | |||
| Open | $12.46 | 52 Week Low | $9.63 | |||
| Day High | $12.83 | P/E | N/A | |||
| Day Low | $12.25 | EPS | $0.00 | |||
| Volume | 1,388,656 | |||||

